Workshop on integration site analysis during long term follow-up for gene therapies with integrating viral vectors (Catapult’s regulatory round-up – September 2024)
On 14th November 2024, the FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors. In this workshop a panel of external experts will discuss the risk of insertional mutagenesis and best practices for ISA method design, data analysis, and clinical inter...
Publication Details
- Journal
- Industrias Culturais (Universidade de Coimbra)
- Published
- 2024-11-19
- DOI
- https://doi.org/10.58079/12prz
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00